Bank of America set a CHF 360 price objective on Roche Holding Ltd. Genussscheine (VTX:ROG) in a report issued on Tuesday, Borsen Zeitung reports. The brokerage currently has a buy rating on the healthcare company’s stock.
Several other brokerages have also recently commented on ROG. Barclays set a CHF 365 target price on shares of Roche Holding Ltd. Genussscheine and gave the company a buy rating in a research report on Thursday, January 16th. JPMorgan Chase & Co. set a CHF 375 price target on shares of Roche Holding Ltd. Genussscheine and gave the stock a buy rating in a report on Wednesday, January 8th. Jefferies Financial Group set a CHF 345 price target on shares of Roche Holding Ltd. Genussscheine and gave the stock a buy rating in a research report on Tuesday, December 17th. Credit Suisse Group set a CHF 340 price objective on shares of Roche Holding Ltd. Genussscheine and gave the company a neutral rating in a research report on Thursday, January 16th. Finally, UBS Group set a CHF 350 target price on Roche Holding Ltd. Genussscheine and gave the stock a buy rating in a research note on Friday, January 10th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and eight have assigned a buy rating to the company’s stock. The company presently has an average rating of Buy and a consensus target price of CHF 328.92.
Roche Holding Ltd. Genussscheine has a 52-week low of CHF 214.30 and a 52-week high of CHF 273.
Rogers Corporation designs, develops, manufactures, and sells engineered materials and components worldwide. The company's Advanced Connectivity Solutions segment offers circuit materials and solutions for connectivity applications in wireless communications infrastructure, automotive, connected devices, wired infrastructure, consumer electronics, and aerospace/defense.
Featured Article: Compound Annual Growth Rate (CAGR)
Receive News & Ratings for Roche Holding Ltd. Genussscheine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. Genussscheine and related companies with MarketBeat.com's FREE daily email newsletter.